Synta Pharmaceuticals Announces Proposed Public Offering of Common Stock

Synta Pharmaceuticals Corp. (NASDAQ: SNTA ) today announced that it has commenced an underwritten public offering of shares of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as